Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Jiangxi Hypertension Research Institute, Nanchang, China.
Clin Cardiol. 2023 Jan;46(1):41-48. doi: 10.1002/clc.23933. Epub 2022 Oct 8.
We aimed to explore the potential role of N-terminal pro-B-type natriuretic peptide (NT-proBNP), d-dimer, and the echocardiographic parameter left atrial diameter (LAD) in identifying and predicting the occurrence of ischemic stroke (IS) in patients with nonvalvular atrial fibrillation (NVAF).
We conducted a retrospective study of 445 patients with NVAF in the First Affiliated Hospital of Nanchang University. They were divided into the NVAF (309 cases) and NVAF with stroke (136 cases) groups according to whether acute ischemic stroke (AIS) occurred at admission. Multivariate logistic regression was used to analyze the odds ratio (OR) of NT-proBNP, d-dimer, and LAD for IS. The predictive value of NT-proBNP, d-dimer, and LAD in identifying the occurrence of IS in NVAF was determined by plotting the receiver operating characteristic (ROC) curves.
NT-proBNP, d-dimer, and LAD levels were significantly higher in the NVAF with stroke group than in the NVAF group (p < .05). NT-ProBNP, d-dimer, and LAD were independently associated with IS in NVAF patients (odds ratio [OR] = 1.12, 95% confidence interval [CI]: 1.08-1.16; OR = 1.87, 95% CI: 1.37-2.55; OR = 1.21, 95% CI: 1.13-1.28, p < .01). The optimal cutoff points for NT-ProBNP, d-dimer, and LAD levels to distinguish the NVAF group from the NVAF with stroke group were 715.0 pg/ml, 0.515 ng/ml, and 38.5 mm, respectively, with the area under the curve (AUC) being [0.801 (95% CI: 0.76-0.84); 0.770 (95% CI: 0.72-0.85); 0.752 (95% CI: 0.71-0.80), p < .01]. The combined score of NT-proBNP, d-dimer, and LAD improved the predictive efficacy of the single index, with an AUC of 0.846 (95% CI: 0.81-0.88, p < .01), sensitivity of 77.2%, and specificity of 76.4%.
NT-proBNP, d-dimer, and the echocardiographic parameter LAD have outstanding value in predicting the risk of IS in patients with NVAF.
本研究旨在探讨氨基末端脑钠肽前体(NT-proBNP)、D-二聚体和超声心动图左心房直径(LAD)在识别和预测非瓣膜性心房颤动(NVAF)患者缺血性脑卒中(IS)发生中的潜在作用。
我们对南昌大学第一附属医院的 445 例 NVAF 患者进行了回顾性研究。根据入院时是否发生急性缺血性脑卒中(AIS),将患者分为 NVAF(309 例)和 NVAF 合并脑卒中(136 例)组。采用多变量逻辑回归分析 NT-proBNP、D-二聚体和 LAD 对 IS 的比值比(OR)。通过绘制受试者工作特征(ROC)曲线来确定 NT-proBNP、D-二聚体和 LAD 在识别 NVAF 中 IS 发生的预测价值。
NVAF 合并脑卒中组的 NT-proBNP、D-二聚体和 LAD 水平明显高于 NVAF 组(p<0.05)。NT-ProBNP、D-二聚体和 LAD 与 NVAF 患者的 IS 独立相关(OR=1.12,95%CI:1.08-1.16;OR=1.87,95%CI:1.37-2.55;OR=1.21,95%CI:1.13-1.28,p<0.01)。NT-ProBNP、D-二聚体和 LAD 水平区分 NVAF 组和 NVAF 合并脑卒中组的最佳截断值分别为 715.0 pg/ml、0.515 ng/ml 和 38.5 mm,曲线下面积(AUC)分别为[0.801(95%CI:0.76-0.84);0.770(95%CI:0.72-0.85);0.752(95%CI:0.71-0.80),p<0.01]。NT-proBNP、D-二聚体和 LAD 的联合评分提高了单项指标的预测效能,AUC 为 0.846(95%CI:0.81-0.88,p<0.01),敏感度为 77.2%,特异性为 76.4%。
NT-proBNP、D-二聚体和超声心动图参数 LAD 在预测 NVAF 患者 IS 风险方面具有显著价值。